Biomotion Sciences Warrant Net Income
| SLXNW Stock | 0.03 0.00 0.000003% |
As of the 18th of February 2026, Biomotion Sciences shows the Mean Deviation of 11.69, downside deviation of 13.19, and Risk Adjusted Performance of 0.0588. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Biomotion Sciences, as well as the relationship between them. Please confirm Biomotion Sciences variance and potential upside to decide if Biomotion Sciences is priced correctly, providing market reflects its regular price of 0.032600001 per share. As Biomotion Sciences appears to be a penny stock we also recommend to validate its total risk alpha numbers.
Biomotion Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biomotion Sciences' valuation are provided below:Quarterly Earnings Growth 1.598 |
| Last Reported | Projected for Next Year | ||
| Net Loss | -14.9 M | -14.1 M | |
| Net Loss | -14.9 M | -14.1 M | |
| Net Loss | (3.03) | (3.18) | |
| Net Income Per E B T | 0.90 | 0.78 |
Biomotion | Net Income | Build AI portfolio with Biomotion Stock |
The evolution of Net Income for Biomotion Sciences Warrant provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Biomotion Sciences compares to historical norms and industry peers.
Latest Biomotion Sciences' Net Income Growth Pattern
Below is the plot of the Net Income of Biomotion Sciences Warrant over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Biomotion Sciences financial statement analysis. It represents the amount of money remaining after all of Biomotion Sciences Warrant operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Biomotion Sciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biomotion Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (16.52 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Biomotion Net Income Regression Statistics
| Arithmetic Mean | (3,092,242) | |
| Geometric Mean | 588,362 | |
| Coefficient Of Variation | (189.64) | |
| Mean Deviation | 4,455,705 | |
| Median | (195,860) | |
| Standard Deviation | 5,864,225 | |
| Sample Variance | 34.4T | |
| Range | 17M | |
| R-Value | (0.70) | |
| Mean Square Error | 18.6T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | (815,920) | |
| Total Sum of Squares | 550.2T |
Biomotion Net Income History
Other Fundumenentals of Biomotion Sciences
Biomotion Sciences Net Income component correlations
Biomotion Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Biomotion Sciences is extremely important. It helps to project a fair market value of Biomotion Stock properly, considering its historical fundamentals such as Net Income. Since Biomotion Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biomotion Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biomotion Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
What growth prospects exist in Stock sector? Can Biomotion capture new markets? Factors like these will boost the valuation of Biomotion Sciences. If investors know Biomotion will grow in the future, the company's valuation will be higher. Valuation analysis balances hard financial data with qualitative growth assessments. While each Biomotion Sciences valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Understanding Biomotion Sciences requires distinguishing between market price and book value, where the latter reflects Biomotion's accounting equity. The concept of intrinsic value - what Biomotion Sciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Market sentiment, economic cycles, and investor behavior can push Biomotion Sciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Biomotion Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomotion Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Biomotion Sciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Biomotion Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biomotion Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biomotion Sciences.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Biomotion Sciences on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Biomotion Sciences Warrant or generate 0.0% return on investment in Biomotion Sciences over 90 days. Biomotion Sciences is related to or competes with Dermata Therapeutics, P3 Health, Revelation Biosciences, Aclarion, Purple Biotech, and Akari Therapeutics. Biomotion Sciences is entity of United States More
Biomotion Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biomotion Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biomotion Sciences Warrant upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 13.19 | |||
| Information Ratio | 0.0587 | |||
| Maximum Drawdown | 79.5 | |||
| Value At Risk | (24.05) | |||
| Potential Upside | 34.33 |
Biomotion Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomotion Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biomotion Sciences' standard deviation. In reality, there are many statistical measures that can use Biomotion Sciences historical prices to predict the future Biomotion Sciences' volatility.| Risk Adjusted Performance | 0.0588 | |||
| Jensen Alpha | 1.2 | |||
| Total Risk Alpha | 0.1182 | |||
| Sortino Ratio | 0.073 | |||
| Treynor Ratio | (0.23) |
Biomotion Sciences February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0588 | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 11.69 | |||
| Semi Deviation | 12.0 | |||
| Downside Deviation | 13.19 | |||
| Coefficient Of Variation | 1613.96 | |||
| Standard Deviation | 16.4 | |||
| Variance | 268.9 | |||
| Information Ratio | 0.0587 | |||
| Jensen Alpha | 1.2 | |||
| Total Risk Alpha | 0.1182 | |||
| Sortino Ratio | 0.073 | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 79.5 | |||
| Value At Risk | (24.05) | |||
| Potential Upside | 34.33 | |||
| Downside Variance | 174.02 | |||
| Semi Variance | 143.99 | |||
| Expected Short fall | (15.20) | |||
| Skewness | 0.8133 | |||
| Kurtosis | 1.1 |
Biomotion Sciences Backtested Returns
Biomotion Sciences is out of control given 3 months investment horizon. Biomotion Sciences secures Sharpe Ratio (or Efficiency) of 0.0748, which signifies that the company had a 0.0748 % return per unit of risk over the last 3 months. We were able to interpolate twenty-six different technical indicators, which can help you to evaluate if expected returns of 1.22% are justified by taking the suggested risk. Use Biomotion Sciences Mean Deviation of 11.69, risk adjusted performance of 0.0588, and Downside Deviation of 13.19 to evaluate company specific risk that cannot be diversified away. Biomotion Sciences holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -4.42, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Biomotion Sciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Biomotion Sciences is expected to outperform it. Use Biomotion Sciences jensen alpha, potential upside, as well as the relationship between the Potential Upside and daily balance of power , to analyze future returns on Biomotion Sciences.
Auto-correlation | -0.27 |
Weak reverse predictability
Biomotion Sciences Warrant has weak reverse predictability. Overlapping area represents the amount of predictability between Biomotion Sciences time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biomotion Sciences price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Biomotion Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.27 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Biomotion Operating Income
Operating Income |
|
Based on the recorded statements, Biomotion Sciences Warrant reported net income of (16.52 Million). This is 104.84% lower than that of the Healthcare sector and 123.58% lower than that of the Biotechnology industry. The net income for all United States stocks is 102.89% higher than that of the company.
Biomotion Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomotion Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomotion Sciences could also be used in its relative valuation, which is a method of valuing Biomotion Sciences by comparing valuation metrics of similar companies.Biomotion Sciences is currently under evaluation in net income category among its peers.
Biomotion Fundamentals
| Return On Equity | -7.71 | |||
| Return On Asset | -0.78 | |||
| Number Of Shares Shorted | 7.72 K | |||
| EBITDA | (16.43 M) | |||
| Net Income | (16.52 M) | |||
| Total Debt | 4.49 M | |||
| Book Value Per Share | 2.23 X | |||
| Cash Flow From Operations | (8.4 M) | |||
| Number Of Employees | 11 | |||
| Beta | -0.035 | |||
| Total Asset | 2.86 M | |||
| Retained Earnings | (43.25 M) | |||
| Working Capital | (1.27 M) | |||
| Net Asset | 2.86 M |
About Biomotion Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomotion Sciences Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomotion Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomotion Sciences Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biomotion Stock Analysis
When running Biomotion Sciences' price analysis, check to measure Biomotion Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomotion Sciences is operating at the current time. Most of Biomotion Sciences' value examination focuses on studying past and present price action to predict the probability of Biomotion Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomotion Sciences' price. Additionally, you may evaluate how the addition of Biomotion Sciences to your portfolios can decrease your overall portfolio volatility.